A61L 2300/432
Inhibitors, antagonists
Official title: Inhibitors, antagonists (A61L2300/402 - A61L2300/43 take precedence)
A61L2300/432 (Inhibitors, antagonists) appears on 346 US grants and 764 published applications in this corpus.
Search patents in A61L- Granted patents
- 346
- Published applications
- 764
- Assignees
- 349
- Inventors
- 1,203
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 6 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 9 | 4 |
| 2002 | 6 | 12 |
| 2003 | 3 | 27 |
| 2004 | 9 | 25 |
| 2005 | 4 | 86 |
| 2006 | 7 | 34 |
| 2007 | 3 | 31 |
| 2008 | 8 | 40 |
| 2009 | 2 | 33 |
| 2010 | 16 | 28 |
| 2011 | 10 | 33 |
| 2012 | 15 | 27 |
| 2013 | 11 | 21 |
| 2014 | 27 | 26 |
| 2015 | 22 | 50 |
| 2016 | 24 | 40 |
| 2017 | 23 | 21 |
| 2018 | 20 | 33 |
| 2019 | 19 | 33 |
| 2020 | 11 | 22 |
| 2021 | 14 | 33 |
| 2022 | 11 | 32 |
| 2023 | 14 | 21 |
| 2024 | 16 | 25 |
| 2025 | 11 | 14 |
| 2026 | 7 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Automated assessment of wound tissue11 Aug 2026US 12,702,663 B2AstraZeneca AB
- Injectable composition and use of said composition12 May 2026US 12,622,863 B2Innate S.R.L.
- Tubular nonwoven structure as active agent carrier for the atraumatic treatment of hollow organs, and a process for producing the same5 May 2026US 12,616,781 B2BVS—Best Vascular Solutions GmbH
- Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation14 Apr 2026US 12,599,663 B2Valitor, Inc.
- Drug delivery system and methods of using the same14 Apr 2026US 12,599,701 B2Axogen Corporation
- Target for combatting the foreign body response to implantable biomaterials1 Oct 2026US 2026/0295119 A1The Regents of the University of Colorado, a body corporate
- Composition for preventing or treating capsular contracture caused by implant surgery and use thereof1 Oct 2026US 2026/0295124 A1Soonchunhyang University Industry Academy Cooperation Foundation
- A suprachoroidal spacer implant to treat glaucoma20 Aug 2026US 2026/0240682 A1The Board of Trustees of the Leland Stanford Junior University
- Drug delivery system and methods of using the same30 Jul 2026US 2026/0216403 A1Axogen Corporation
- New Hyaluronan Hydrogels Chemically Crosslinked By MMP Inhibitors23 Jul 2026US 2026/0209395 A1Consorzio Interuniversitario Nazionale Per La Scienza E Tecnologia Dei Materiali
Most cited
By later US patents
- Embolization plugs for blood vessels471US 5,456,693 AVitaphore Corporation · 1995
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Biodegradable matrix and methods for producing same339US 4,703,108 AUniversity of Medicine and Dentistry of New Jersey · 1987
- Biodegradable matrix and methods for producing same314US 4,970,298 AUniversity of Medicine and Dentistry of New Jersey · 1990
- Compositions for efficient release of active ingredients263US 6,716,441 B1The Procter & Gamble Company · 2004